- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01186718
Interexaminer Reliability, Outcomes for Manipulation of Cervical Dysfunction, 3-D Kinematics
Three-dimensional Study of Cervical Kinematics
Study Overview
Status
Conditions
Detailed Description
Our primary hypothesis is that kinematic changes will be detected after OMT for motions in the primary direction of the passive diagnostic test motions (cervical side-bending right and left), as well as angular rotations (deviations) occurring around these motions. Our secondary hypothesis is that examination of the kinematic data will provide objective inter- and intra-examiner data to assess similarities/differences occurring during the passive clinical exam before and after OMT. Lastly, we hypothesize that significant differences in the kinematic patterns will result between the two subject groups.
This experiment is designed for the following clinical and biomechanical observations:
- comparisons of diagnostic data between three osteopathic physicians,
- comparisons of within-subject kinematic profiles pre- and post-treatment,
- inter-examiner comparisons of kinematic motion paths occurring during diagnostic motions,
- evaluate kinematic patterns between the two subject groups, and assess between group similarities/differences,
- evaluate diagnostic and kinematic data relative to VAS, cervical disability, health status information, and SNF,
- re-classify aspects of the kinematic data using a cluster (statistical) analysis procedure to compare with initial and secondary physician diagnostic data, and
- to assess the stability of changes made by the OMT procedures and the kinematic response three days post-treatment.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Michigan
-
East Lansing, Michigan, United States, 48824
- Michigan State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Cervical motion symmetry and asymmetry
Exclusion Criteria:
- Under 18 years of age
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Control Group
Control group = functional symmetric cervical motion.
|
Experimental subject group
Experimental subject group = asymmetric cervical motion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
3-D kinematic measurements of cervical motion
Time Frame: 9/2009 to 8/2011
|
9/2009 to 8/2011
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Joseph Vorro, Phd, Michigan State University Dept. Family Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AOA 09-05-581
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Cervical Motions
-
National Cancer Institute (NCI)Active, not recruitingHuman Papillomavirus-Related Cervical CarcinomaCosta Rica
-
Becton, Dickinson and CompanyCompletedHuman Papillomavirus | Cervical NeoplasmsUnited States, Canada
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedCervical Cancer | Uterine Cervical Neoplasms | Human PapillomavirusUnited States
-
Purnima MadhivananFlorida International UniversityUnknownCervical Cancer | Human PapillomavirusIndia
-
Preventive Oncology International, Inc.Merck Sharp & Dohme LLC; Peru Instituto Nacional de Enfermadades Neoplasticas...CompletedCervical Cancer | Cervical Intraepithelial Neoplasia | Human Papillomavirus | Cervical Dysplasia | Cervical NeoplasmPeru
-
National Cancer Institute (NCI)CompletedCervical Intraepithelial Neoplasia | Uterine Cervical Neoplasms | Human Papillomavirus 16 | Human Papillomavirus 18Nigeria
-
Preventive Oncology International, Inc.Peking University Shenzhen HospitalCompletedCervical Cancer | Cervical Intraepithelial Neoplasia | Human Papillomavirus | Cervical Dysplasia | Cervical NeoplasmChina
-
Hospital General de México Dr. Eduardo LiceagaUnknownHPV DNA | Human Papillomavirus (HPV)-Related Cervical CancerMexico
-
Karolinska InstitutetRegional Cancer Centre Stockholm GotlandUnknownCervical Cancer | Human Papillomavirus DNA Tests
-
University of British ColumbiaUganda Cancer InstituteCompletedCervical Cancer | Papillomavirus Infections | Pre-Cancerous Dysplasia | Human Papillomavirus 16 | Human Papillomavirus 18Uganda